ZA942728B - Substituted phenoxyisobutryric acids and esters - Google Patents
Substituted phenoxyisobutryric acids and estersInfo
- Publication number
- ZA942728B ZA942728B ZA942728A ZA942728A ZA942728B ZA 942728 B ZA942728 B ZA 942728B ZA 942728 A ZA942728 A ZA 942728A ZA 942728 A ZA942728 A ZA 942728A ZA 942728 B ZA942728 B ZA 942728B
- Authority
- ZA
- South Africa
- Prior art keywords
- radical
- hydrogen atom
- atom
- straight
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9304606A FR2704224B1 (fr) | 1993-04-20 | 1993-04-20 | Nouveaux acides et esters phénoxy isobutyriques substitués. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA942728B true ZA942728B (en) | 1995-02-09 |
Family
ID=9446213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA942728A ZA942728B (en) | 1993-04-20 | 1994-04-20 | Substituted phenoxyisobutryric acids and esters |
Country Status (13)
Country | Link |
---|---|
US (2) | US5512595A (xx) |
EP (1) | EP0621255B1 (xx) |
JP (1) | JP2885639B2 (xx) |
AT (1) | ATE157077T1 (xx) |
AU (1) | AU667266B2 (xx) |
CA (1) | CA2121571C (xx) |
DE (1) | DE69405036T2 (xx) |
DK (1) | DK0621255T3 (xx) |
ES (1) | ES2105549T3 (xx) |
FR (1) | FR2704224B1 (xx) |
GR (1) | GR3024942T3 (xx) |
NZ (1) | NZ260350A (xx) |
ZA (1) | ZA942728B (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006202461B2 (en) * | 1997-05-14 | 2009-12-03 | Atherogenics, Inc. | Compositions and methods for the inhibition of the expression of VCAM-1 |
US6852878B2 (en) | 1998-05-14 | 2005-02-08 | Atherogenics, Inc. | Thioketals and thioethers for inhibiting the expression of VCAM-1 |
US6670398B2 (en) | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
EA200800375A1 (ru) | 1997-05-14 | 2008-06-30 | Атеродженикс, Инк. | Соединения и способы ингибирования экспрессии vcam-1 |
EP1695959A1 (en) * | 1997-05-14 | 2006-08-30 | Atherogenics, Inc. | Compouds and methods for the inhibition of the expression of VCAM-1 |
AU8282798A (en) | 1997-07-01 | 1999-01-25 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
AU2001247651B2 (en) * | 2000-03-21 | 2007-01-04 | Atherogenics, Inc | Thioketals and thioethers for inhibiting the expression of vcam-1 |
EP1272465A2 (en) | 2000-04-11 | 2003-01-08 | Atherogenics, Inc. | Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality |
JP4334233B2 (ja) * | 2001-04-11 | 2009-09-30 | アセロジエニクス・インコーポレイテツド | プロブコールモノエステルによって血漿hdlコレステロールレベルを上昇させ、hdlの機能性を改善するための方法 |
US20040110803A1 (en) * | 2002-09-13 | 2004-06-10 | Hossein Dovlatabadi | Methods and compositions for the use of D-malic acid to decrease serum triglyceride, cholesterol and lipoprotein levels |
AU2002953533A0 (en) * | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
MXPA05007548A (es) * | 2003-01-13 | 2005-10-20 | Atherogenics Inc | Procedimiento para preparar esteres y eteres de probucol y derivados del mismo. |
WO2005102323A2 (en) | 2004-04-20 | 2005-11-03 | Atherogenics, Inc. | Process of preparing esters and ethers of probucol and derivatives thereof |
WO2005112914A2 (en) | 2004-04-20 | 2005-12-01 | Atherogenics, Inc. | Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease |
WO2006063294A2 (en) * | 2004-12-09 | 2006-06-15 | Kalypsys, Inc. | Novel inhibitors of histone deacetylase for the treatment of disease |
AU2008230861A1 (en) * | 2007-03-26 | 2008-10-02 | Salutria Pharmaceuticals, Llc | Methods and compositions of derivatives of probucol for the treatment of diabetes |
US20080280985A1 (en) * | 2007-03-27 | 2008-11-13 | Scott Robert A D | Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes |
KR102233327B1 (ko) * | 2013-12-26 | 2021-03-26 | 스미또모 가가꾸 가부시끼가이샤 | 할로겐 치환 프탈리드의 제조 방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE345734C (xx) * | 1962-11-19 | |||
GB1288841A (xx) * | 1970-04-14 | 1972-09-13 | ||
GB1394260A (en) * | 1972-10-24 | 1975-05-14 | Ici Ltd | Esters of alpha-tocopherol |
US4039683A (en) * | 1973-08-21 | 1977-08-02 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Phenoxypropionic acid derivatives and pharmaceutical preparations containing same |
GB1565972A (en) * | 1976-04-15 | 1980-04-23 | Sori Soc Rech Ind | M-substituted phenoxypropionic acid dervatives |
CA2020437A1 (en) * | 1989-07-05 | 1991-01-06 | Yoshihide Fuse | Cinnamamide derivative |
-
1993
- 1993-04-20 FR FR9304606A patent/FR2704224B1/fr not_active Expired - Fee Related
-
1994
- 1994-04-18 AU AU60533/94A patent/AU667266B2/en not_active Ceased
- 1994-04-18 CA CA002121571A patent/CA2121571C/fr not_active Expired - Fee Related
- 1994-04-19 DE DE69405036T patent/DE69405036T2/de not_active Expired - Fee Related
- 1994-04-19 ES ES94400845T patent/ES2105549T3/es not_active Expired - Lifetime
- 1994-04-19 DK DK94400845.7T patent/DK0621255T3/da active
- 1994-04-19 US US08/230,143 patent/US5512595A/en not_active Expired - Fee Related
- 1994-04-19 NZ NZ260350A patent/NZ260350A/en unknown
- 1994-04-19 EP EP94400845A patent/EP0621255B1/fr not_active Expired - Lifetime
- 1994-04-19 AT AT94400845T patent/ATE157077T1/de not_active IP Right Cessation
- 1994-04-20 ZA ZA942728A patent/ZA942728B/xx unknown
- 1994-04-20 JP JP6081869A patent/JP2885639B2/ja not_active Expired - Lifetime
-
1995
- 1995-08-03 US US08/510,857 patent/US5627205A/en not_active Expired - Fee Related
-
1997
- 1997-10-06 GR GR970402583T patent/GR3024942T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH06340580A (ja) | 1994-12-13 |
GR3024942T3 (en) | 1998-01-30 |
DE69405036D1 (de) | 1997-09-25 |
US5627205A (en) | 1997-05-06 |
AU6053394A (en) | 1994-10-27 |
DE69405036T2 (de) | 1998-03-26 |
JP2885639B2 (ja) | 1999-04-26 |
NZ260350A (en) | 1995-10-26 |
US5512595A (en) | 1996-04-30 |
EP0621255B1 (fr) | 1997-08-20 |
FR2704224A1 (fr) | 1994-10-28 |
EP0621255A1 (fr) | 1994-10-26 |
ATE157077T1 (de) | 1997-09-15 |
DK0621255T3 (da) | 1998-04-06 |
CA2121571C (fr) | 2000-08-01 |
CA2121571A1 (fr) | 1994-10-21 |
FR2704224B1 (fr) | 1995-08-25 |
ES2105549T3 (es) | 1997-10-16 |
AU667266B2 (en) | 1996-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA942728B (en) | Substituted phenoxyisobutryric acids and esters | |
GR78508B (xx) | ||
DE69103206D1 (de) | Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel. | |
DE69423802D1 (de) | Indolderivate als 5-HT1-like Agonisten | |
KR880007461A (ko) | 헤테로 사이클-치환 디포스포네이트화합물 및 이의 약제학적 조성물 | |
ATE192143T1 (de) | Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE155140T1 (de) | 3-deoxyoligosacchariden, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE3874396D1 (de) | 1,2,5,6-tetrahydropyridin-derivate, verfahren zur herstellung, verwendung als heilmittel und zusammenstellungen, die sie enthalten. | |
AU6597790A (en) | Use of 6- or 7-hydroxyindole derivatives as couplers and dyeing compositions and methods using these | |
DK0696585T3 (da) | Nyt bisoxadiazolidinderivat | |
ATE201022T1 (de) | Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte | |
DE59206593D1 (de) | Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe | |
ES402638A1 (es) | Procedimiento para la preparacion de fenilaminoalcanos. | |
DE3764918D1 (de) | 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
FI891033A (fi) | Lim. | |
DE3785963D1 (de) | Dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |